Abmart

Abmart is a leading biotechnology company headquartered in Shanghai that specializes in high-throughput antibody discovery and large-scale manufacturing. The company has pioneered the Seal and MAb-Array platforms, which enable the rapid generation and validation of monoclonal antibodies against the entire human proteome. Abmart operates as a comprehensive service provider, offering custom antibody development, screening, and CDMO services to global pharmaceutical and research institutions. Beyond its service portfolio, the company leverages its massive antibody library to develop an internal pipeline of therapeutic candidates targeting oncology and inflammatory diseases. With a focus on industrializing antibody production, Abmart aims to accelerate the transition from target identification to clinical application.